Email this article TINJAUAN TERKINI COVID-19 PADA MATA DAN KULIT
Abstract
Pandemi COVID-19 telah mengakibatkan banyak morbiditas dan mortalitas di seluruh dunia. Virus SARS-CoV2 terutama menular lewat droplet pernafasan, dan masuk ke tubuh menusia berikatan dengan reseptor Angiotensin-converting enzyme II (ACE2) melaui protein spike. Beberapa studi menemukan bahwa COVID-19 mungkin juga dapat menular melalui organ mata dan kulit, karena reseptor ACE2 yang juga terdapat di dalamnya. COVID-19 memiliki manifestasi yang bervariasi pada mata dan kulit, baik sebagai gejala awal penyakit atau gejala yang muncul selama rawat inap. Alat pelindung diri (APD) dan vaksinasi telah banyak digunakan dengan tujuan menghentikan penyebaran infeksi virus, dan sejumlah efek samping pada mata dan kulit telah dilaporkan dalam literatur. Tinjauan pustaka ini bertujuan memberikan telaah terkini dari manifestasi klinis serta komplikasi pencegahan dan vaksinasi COVID-19 pada mata dan kulit.
Keywords
Full Text:
PDF (Bahasa Indonesia)References
World Health Organization. COVID-19 weekly epidemiological update, edition 123, 21 December 2022. (Online) 21 Desember 2022 di https://apps.who.int/iris/handle/10665/365535. [diakses tanggal 15 Februari 2023].
Eissa M, Abdelrazek NA, Saady M. Covid-19 and its relation to the human eye: transmission, infection, and ocular manifestations. Graefes Arch Clin Exp Ophthalmol. 2020;00:1–10.
Ho D, Low R, Tong L, Gupta V, Veeraraghavan, Agrawal R. COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations. Ocul Immunol Inflamm. 2020;28(5):726-34.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and application. Annals of Internal Medicine. 2020;172(9):577–82.
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427.
Xue X, Mi Z, Wang Z, Pang Z, Liu H, Zhang F. High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2. J Invest Dermatol. 2021;141(1):206-9.e1.
Xu Q, Zhang L, Chen L, Zhao X, Wang X, Hu M, et al. SARS-CoV-2 might transmit through the skin while the skin barrier function could be the mediator. Med Hypotheses. 2022;159:110752.
Salamanna F, Maglio M, Landini MP, Fini M. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2. Front Med (Lausanne). 2020;7:594495.
Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 Vaccines and the Skin: The Landscape of Cutaneous Vaccine Reactions Worldwide. Dermatol Clin. 2021;39(4):653-73.
Güemes-Villahoz N, Burgos-Blasco B, García-Feijoó J, Sáenz-Francés F, Arriola-Villalobos P, Martinez-de-la-Casa JM, et al. Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2501-7.
Bayram N, Ozsayg?l? C, Sav H, Tekin Y, Gundogan M, Pangal E, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021;65(4):515-25.
Invernizzi A, Torre A, Parrulli S, Zicarelli F, Schiuma M, Colombo V, et al. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550.
Romero-Castro RM, Ruiz-Cruz M, Alvarado-de la Barrera C, González-Cannata MG, Luna-Villalobos YA, García-Morales AK, et al. Posterior Segment Ocular Findings In Critically Ill Patients With COVID-19. Retina. 2022;42(4):628-33.
Fonollosa A, Hernández-Rodríguez J, Cuadros C, Giralt L, Sacristán C, Artaraz J, et al. CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature. Retina. 2022;42(3):465-475
Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-5.
Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, et al. The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118-29.
Dalal A, Jakhar D, Agarwal V, Beniwal R. Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India. Dermatol Ther. 2020;33(6):e13849.
De Giorgi V, Recalcati S, Jia Z, Chong W, Ding R, Deng Y, et al. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy. J Am Acad Dermatol. 2020;83(2):674-5.
Askin O, Altunkalem RN, Altinisik DD, Uzuncakmak TK, Tursen U, Kutlubay Z. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19. Dermatol Ther. 2020;33(6):1-6.
Karakus S. COVID Conjunctivitis. (Online) 30 Juni 2022 di https://eyewiki.aao.org/COVID_Conjunctivitis. [diakses tanggal 21 Februari 2023].
Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Conjunctivitis and COVID-19: A meta-analysis. J Med Virol. 2020;92(9):1413-4.
Hu K, Patel J, Swiston C, Patel BC. 2022. Ophthalmic Manifestations Of Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing
Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575-8.
Ma N, Li P, Wang X, Yu Y, Tan X, Chen P, at al. Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China. JAMA Ophthalmol. 2020;138(10):1079-86.
Fernández Alcalde C, Granados Fernández M, Nieves Moreno M, Calvo Rey C, Falces Romero I, Noval Martín S. COVID-19 ocular findings in children: a case series. World J Pediatr. 2021;17(3):329-34.
Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020;127(7):977-9.
Arora R, Goel R, Kumar S, Chhabra M, Saxena S, Manchanda V, et al. Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19. Ophthalmology. 2021;128(4):494-503.
Lv Z, Cheng S, Le J, Huang J, Feng L, Zhang B, et al. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study. Microbes Infect. 2020;22(4-5):195-9.
Remppis J, Ganzenmueller T, Kohns Vasconcelos M, Heinzel O, Handgretinger R, Renk H. A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19. BMC Infect Dis. 2021;21(1):133.
Mahdjoubi A, Bousnina Y, Barrande G, Bensmaine F, Chahed S, Ghezzaz A. Features of cotton wool spots in diabetic retinopathy: a spectral-domain optical coherence tomography angiography study. Int Ophthalmol. 2020;40:1625-40.
Gavriilaki E, Brodsky RA. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol. 2020;189(6):e227-30.
Abuelgasim E, Dona ACM, Sondh RS & Harky A. Management of urticaria in COVID-19 patients: A systematic review. Dermatol Ther. 2021;34(1):e14328.
Ghimire K & Adhikari N. Morbilliform rashes in a patient with covid-19 infection: A case report. JNMA J Nepal Med Assoc. 2021;59(236):399-401.
Genovese G, Moltrasio C, Berti E & Marzano AV. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatol. 2021;237(1):1–12.
Klejtman T. Skin and COVID-19. J Med Vasc. 2020;45(4):175-6.
Casas CG, Català A, Hernández GC, Rodríguez-Jiménez P, Fernández-Nieto D, Lario ARV, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-7.
Shanshal M. Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria. J Dermatolog Treat. 2020;33(2):1140-1.
Seque CA, Enokihara MMSES, Porro AM, Tomimori J. Skin manifestations associated with COVID-19. An Bras Dermatol. 2022;97(1):75-88.
Fernández-Lázaro D, Garrosa M. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. Viruses. 2021;13(10):1916.
Naderi-Azad S, Vender R. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns. J Cutan Med Surg. 2021;25(2):169-76.
Azzam SH, Nama A, Badarni H, Asael H, Dahoud WA, Mimouni M, Zayyad H. Assessment of dry eye disease in N95 versus surgical face mask wearers during COVID-19. Indian J Ophthalmol. 2022;70(3):995-9.
Abiakam N, Worsley P, Jayabal H, Mitchell K, Jones M, Fletcher J, et al. Personal protective equipment related skin reactions in healthcare professionals during COVID-19. Int Wound J. 2021;18(3):312-22.
Yuan X, Xi H, Le Y, Xu H, Wang J, Meng X, et al. Online survey on healthcare skin reactions for wearing medical-grade protective equipment against COVID-19 in Hubei Province, China. PLoS One. 2021;16(4):e0250869.
Wasser LM, Koppel JH, Zadok D, Berkowitz L, Abulafia A, Heiman E, et al. Pediatric Ocular Injury Due to Hand Sanitizer Exposure: An Emerging Hazard. Pediatr Emerg Care. 2021;37(9):462-5.
Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Shaer B, Vishnevskia-Dai V, Shulman S, et al. Uveitis After The BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection: A Possible Association. Retina. 2021;41(12):2462-71.
Testi I, Brandão-de-Resende C, Agrawal R, Pavesio C; COVID-19 Vaccination Ocular Inflammatory Events Study Group. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12(1):4.
Cohen S, Olshaker H, Fischer N, Vishnevskia-Dai V, Hagin D, Rosenblatt A, et al. Herpetic Eye Disease Following the SARS-CoV-2 Vaccinations. Ocul Immunol Inflamm. 2022;00:1-12.
Netravathi M, Dhamija K, Gupta M, Tamborska A, Nalini A, Holla VV, et al. COVID-19 vaccine associated demyelination & its association with MOG antibody. Mult Scler Relat Disord. 2022;60:103739.
Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC, et al. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: case series and nested case-control study. Lancet Infect Dis. 2022;22(1):64-72.
Higashino T, Yamazaki Y, Senda S, Satou Y, Yonekura Y, Imai K, et al. Assessment of Delayed Large Local Reactions After the First Dose of the SARS-CoV-2 mRNA-1273 Vaccine in Japan. JAMA Dermatol. 2022;158(8):923-7.
McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46-55.
Català A, Muñoz-Santos C, Galván-Casas C, Roncero Riesco M, Revilla Nebreda D, Solá-Truyols A, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2022;186(1):142-52.
World Health Organization. 2020. Technical specifications of personal protective equipment for COVID-19. Geneva: World Health Organization.
Pandey SK, Sharma V. Mask-associated dry eye disease and dry eye due to prolonged screen time: are we heading towards a new dry eye epidemic during the COVID-19 era? Indian J Ophthalmol. 2021;69(2):448-9.
Moshirfar M, West WB, Marx DP. Face mask-associated ocular irritation and dryness. Ophthalmol Ther. 2020;9(3):397–400.
Rhee MSM, Lindquist CD, Silvestrini MT, Chan AC, Ong JJY, Sharma VK. Carbon dioxide increases with face masks but remains below short-term NIOSH limits. BMC Infect Dis. 2021;21(1):354.
Mohseni Afshar Z, Babazadeh A, Hasanpour A, Barary M, Sayad B, Janbakhsh A, et al. Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge. J Med Virol. 2021;93(10):5756-67.
Darlenski R, Kazandjieva J, Tsankov N. Prevention and occupational hazards for the skin during COVID-19 pandemic. Clin Dermatol. 2021;39(1):92-7.
Hu K, Fan J, Li X, Gou X, Li X, Zhou X. The adverse skin reactions of health care workers using personal protective equipment for COVID-19. Medicine (Baltimore). 2020;99(24):e20603.
Yangzes S, Grewal S, Gailson T, Grewal SPS. Hand Sanitizer-Induced Ocular Injury: A COVID-19 Hazard in Children. JAMA Ophthalmol. 2021;139(3):362-4.
Liu HY, Yeh PT, Kuo KT, et al. Toxic keratopathy following the use of alcohol-containing antiseptics in nonocular surgery. JAMA Ophthalmol. 2016;134:449-52.
Martin GC, Le Roux G, Guindolet D, Boulanger E, Hasle D, Morin E, et al. Pediatric Eye Injuries by Hydroalcoholic Gel in the Context of the Coronavirus Disease 2019 Pandemic. JAMA Ophthalmol. 2021;139(3):348-51.
Benage M, Fraunfelder FW. Vaccine-Associated Uveitis. Mo Med. 2016;113(1):48-52.
Singh RB, Parmar UPS, Ichhpujani P, Jeng BH, Jhanji V. Herpetic Eye Disease After SARS-CoV-2 Vaccination: A CDC-VAERS Database Analysis. Cornea. 2023.
Sahin U, Muik A, Vogler I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595:572-7.
Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, et al. Post COVID-19 Vaccination-Associated Neurological Complications. Neuropsychiatr Dis Treat. 2022;18:137-54.
Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease. J Neurol. 2019;266(5):1280-6.
Principi N, Esposito S. Do vaccines have a role as a cause of autoimmune neurological syndromes? Front Public Health 2020;8:361.
Linder T, Bossart W, Bodmer D. Bell's palsy and Herpes simplex virus: fact or mystery? Otol Neurotol. 2005;26(1):109-13.
Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020;5(1):237.
Temiz SA, Abdelmaksoud A, Wollina U, Kutlu O, Dursun R, Patil A, et al. Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review. J Cosmet Dermatol. 2022;21(1):4-12.
Qaderi K, Golezar MH, Mardani A, Mallah MA, Moradi B, Kavoussi H, et al. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review. Dermatol Ther. 2022;35(5):e15391.
Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2022;36(2):172-80.
CDC COVID-19 Response Team; Food and Drug Administration. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(4):125-9.
Freeman EE, Sun Q, McMahon DE, Singh R, Fathy R, Tyagi A, et al. Skin reactions to COVID-19 vaccines: An American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type. J Am Acad Dermatol. 2022;86(4):e165-7.
DOI: https://doi.org/10.32502/sm.v14i1.5848
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Bella Patricia Simanjorang, Margaretha Nathania
License URL: http://creativecommons.org/licenses/by-nd/4.0/
sinta4.png)
